https://www.selleckchem.com/pr....oducts/Mizoribine.ht
155-3.657, =0.014) were independent risk factors for delayed flatus. Increased intravenous fluid infusion at POD1 and duration of stoma ≥6 months were related to delayed recovery of gastrointestinal function after ileostomy reversal for rectal cancer patients. Increased intravenous fluid infusion at POD1 and duration of stoma ≥6 months were related to delayed recovery of gastrointestinal function after ileostomy reversal for rectal cancer patients. We aimed to screen novel genetic biomarkers for use in a prognostic score (PS) model f